Loading
Latest filing published 16 Nov 2021 for Aleafia Health Inc. (formerly Canabo Medical Inc.), €1,313.
No signal scores available.
Matthew Sale is a declared insider of Aleafia Health Inc. (formerly Canabo Medical Inc.), with filings sourced from SEDI. Over a trading history stretching from 21 June 2021 to 15 November 2021, the count stands at 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €1,313. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 16 November 2021, reports an open-market purchase of €1,313 in Aleafia Health Inc. (formerly Canabo Medical Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 8 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations